Close

CTSE

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

CTSE (Cathepsin E) is a Protein Coding gene. Diseases associated with CTSE include Gastric Adenocarcinoma and Rosai-Dorfman Disease. Among its related pathways are Innate Immune System and MHC class II antigen presentation. Gene Ontology (GO) annotations related to this gene include protein homodimerization activity and aspartic-type endopeptidase activity. An important paralog of this gene is PGA3.
  • CAR Vector Products

  • DMAb

Loading...
  • Target Species:
  • Antibody Clone:
  • Antibody Host:
  • Receptor Construction:
  • Vector Type:
  • Targeting Cell Type:
CAT Product Name Target Species Antibody Clone Antibody Host Receptor Construction Vector Type Targeting Cell Type CAR Vector Type Inquiry & Datasheet
CAR-CQ0680 Anti-CTSE (CBXC-0995) h(41BB-CD3ζ) CAR, pCDCAR1 Mouse CBXC-0995 Rat scFv-41BB-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-CQ0681 Anti-CTSE (CBXC-2639) h(41BB-CD3ζ) CAR, pCDCAR1 Mouse CBXC-2639 Rat scFv-41BB-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-CQ0682 Anti-CTSE (CBXC-1013) h(41BB-CD3ζ) CAR, pCDCAR1 Human CBXC-1013 Mouse scFv-41BB-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-CQ4104 Anti-CTSE (CBXC-0995) h(CD28-CD3ζ) CAR, pCDCAR1 Mouse CBXC-0995 Rat scFv-CD28-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-CQ4105 Anti-CTSE (CBXC-2639) h(CD28-CD3ζ) CAR, pCDCAR1 Mouse CBXC-2639 Rat scFv-CD28-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-CQ4106 Anti-CTSE (CBXC-1013) h(CD28-CD3ζ) CAR, pCDCAR1 Human CBXC-1013 Mouse scFv-CD28-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-WFY3027 Anti-CTSE (CBFYC-2442) h(41BB-CD3ζ) CAR, pCDCAR1 Human CBFYC-2442 Mouse scFv-41BB-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-WFY3028 Anti-CTSE (CBFYC-2443) h(41BB-CD3ζ) CAR, pCDCAR1 Mouse CBFYC-2443 Rat scFv-41BB-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-WFY3029 Anti-CTSE (CBFYC-2444) h(41BB-CD3ζ) CAR, pCDCAR1 Mouse CBFYC-2444 Rat scFv-41BB-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-WFY3030 Anti-CTSE (CBFYC-2445) h(41BB-CD3ζ) CAR, pCDCAR1 Human CBFYC-2445 Mouse scFv-41BB-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-WFY3031 Anti-CTSE (CBFYC-2446) h(41BB-CD3ζ) CAR, pCDCAR1 Mouse CBFYC-2446 Rabbit scFv-41BB-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-WFY6280 Anti-CTSE (CBFYC-2442) h(CD28-CD3ζ) CAR, pCDCAR1 Human CBFYC-2442 Mouse scFv-CD28-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-WFY6281 Anti-CTSE (CBFYC-2443) h(CD28-CD3ζ) CAR, pCDCAR1 Mouse CBFYC-2443 Rat scFv-CD28-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-WFY6282 Anti-CTSE (CBFYC-2444) h(CD28-CD3ζ) CAR, pCDCAR1 Mouse CBFYC-2444 Rat scFv-CD28-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-WFY6283 Anti-CTSE (CBFYC-2445) h(CD28-CD3ζ) CAR, pCDCAR1 Human CBFYC-2445 Mouse scFv-CD28-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-WFY6284 Anti-CTSE (CBFYC-2446) h(CD28-CD3ζ) CAR, pCDCAR1 Mouse CBFYC-2446 Rabbit scFv-CD28-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
Unable to find the desired product? Explore the Filter Options at the top of the list.
Key Updates
Newsletter NEWSLETTER

The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders

LEARN MORE NEWSLETTER
New Solution NEW SOLUTION

CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.

LEARN MORE SOLUTION
NOVEL SOLUTION NOVEL TECHNOLOGY

Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.

LEARN MORE NOVEL TECHNOLOGY
NEW TECHNOLOGY NEW SOLUTION

Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.

LEARN MORE SOLUTION
Receive our latest news and insights.